ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,703Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 2094

$1.38M Total Retail Price of All Prescriptions

Rank: 30 out of 2094

663 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 663 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 13,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 555 451 1 2
ATORVASTATIN CALCIUM 531 471 2 5
OMEPRAZOLE 477 370 3 4
FUROSEMIDE 405 368 4 6
METFORMIN HCL 352 274 5 8
LACTULOSE 343 264 6 65
DONEPEZIL HCL 330 287 7 20
SIMVASTATIN 320 301 8 1
RISPERIDONE 305 198 9 56
DIOVAN HCT 293 248 10 28
NAMENDA 258 220 11 32
NIASPAN 247 152 12 145
METOPROLOL TARTRATE 232 188 13 10
TAMSULOSIN HCL 224 219 14 29
POTASSIUM CHLORIDE 222 200 15 24
CARVEDILOL 215 179 16 19
PLAVIX 207 172 17 38
NAPROXEN 202 174 18 84
CLOPIDOGREL 197 177 19 22
METOPROLOL SUCCINATE 191 162 20 9
GLIMEPIRIDE 188 173 21 31
MELOXICAM 185 153 22 49
CELEBREX 184 169 23 74
LISINOPRIL 181 163 24 7
WARFARIN SODIUM 181 181 24 11
HYDROCHLOROTHIAZIDE 175 129 26 12
DIOVAN 171 148 27 13
BYSTOLIC 171 155 27 83
CYMBALTA 157 107 29 61
LYRICA 156 121 30 85
CRESTOR 153 124 31 15
ZOLPIDEM TARTRATE 141 104 32 14
LIPITOR 129 116 33 39
COLCRYS 125 88 34 230
LEVETIRACETAM 117 62 35 78
ESCITALOPRAM OXALATE 113 82 36 46
OLANZAPINE 106 32 37 113
SERTRALINE HCL 106 89 37 26
MUPIROCIN 104 99 39 117
NEXIUM 104 101 39 16
IPRATROPIUM-ALBUTEROL 99 68 41 92
GABAPENTIN 97 72 42 23
ALENDRONATE SODIUM 96 76 43 30
LEVEMIR FLEXPEN 95 46 44 188
ONGLYZA 93 85 45 134
TRAMADOL HCL 93 68 45 33
LEXAPRO 90 67 47 180
BENICAR HCT 88 80 48 133
LEVOTHYROXINE SODIUM 87 69 49 3
NITROGLYCERIN PATCH 87 80 49 101
BENZTROPINE MESYLATE 86 51 R 51 157
ADVAIR DISKUS 86 66 51 36
TRAVATAN Z 86 73 51 189
EXELON 83 75 54 111
PROAIR HFA 83 72 54 45
ACETAMINOPHEN-CODEINE 81 67 S3 56 129
SANTYL 79 64 57 114
ARICEPT 78 65 58 386
PHENYTOIN SODIUM EXTENDED 78 63 58 158
LANTUS 78 68 58 66
CLOTRIMAZOLE-BETAMETHASONE 77 51 61 91
AVODART 76 72 62 163
AZOR 75 75 63 155
CYCLOBENZAPRINE HCL 74 44 R 64 115
BENICAR 74 73 64 108
OXYCODONE-ACETAMINOPHEN 74 40 S2 64 40
ENALAPRIL MALEATE 73 57 67 25
NOVOFINE AUTOCOVER 72 33 68 289
LEVOFLOXACIN 70 50 69 70
TRAZODONE HCL 70 0 69 72
SINGULAIR 70 60 69 64
HYDRALAZINE HCL 69 66 72 89
METOCLOPRAMIDE HCL 68 49 73 141
CIPROFLOXACIN HCL 67 53 74 81
LOSARTAN-HYDROCHLOROTHIAZIDE 66 58 75 52
ENOXAPARIN SODIUM 64 64 76 173
LOSARTAN POTASSIUM 63 51 77 17
LANTUS SOLOSTAR 62 41 78 76
ALLOPURINOL 60 32 79 50
ARTHROTEC 75 58 55 10 80 421
ALBUTEROL SULFATE 56 29 81 90
HUMALOG 56 46 81 164
LOVAZA 55 25 83 53
MEGESTROL ACETATE 53 32 R 84 174
EXFORGE 53 44 84 105
RAMIPRIL 51 48 86 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.